+ − Summary
+ − Full Texts (3)
+ − Actions (33)
- Public Act . . . . . . . . . 102-0490
- Governor Approved
- Effective Date January 1, 2023
- Sent to the Governor
- Passed Both Houses
- Third Reading - Passed; 059-000-000
- Placed on Calendar Order of 3rd Reading ** May 28, 2021
- Placed on Calendar Order of 3rd Reading May 25, 2021
- Second Reading
- Placed on Calendar Order of 2nd Reading May 20, 2021
- Do Pass Licensed Activities; 007-000-000
- Assigned to Licensed Activities
- Placed on Calendar Order of First Reading
- Arrive in Senate
- Chief Senate Sponsor Sen. Emil Jones, III
- First Reading
- Referred to Assignments
- Third Reading - Short Debate - Passed 111-000-000
- Placed on Calendar Order of 3rd Reading - Short Debate
- House Floor Amendment No. 1 Adopted
- Recalled to Second Reading - Short Debate
- House Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 017-002-000
- House Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
- House Floor Amendment No. 1 Referred to Rules Committee
- House Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar
- Placed on Calendar Order of 3rd Reading - Short Debate
- Second Reading - Short Debate
- Placed on Calendar 2nd Reading - Short Debate
- Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 018-000-000
- Assigned to Prescription Drug Affordability & Accessibility Committee
- Referred to Rules Committee
- First Reading
- Filed with the Clerk by Rep. Dagmara Avelar
+ − Adopted Amendment
House Amendment 001
Replaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Provides that notwithstanding any other provision of law, a prescription for a substance classified in Schedule II, III, IV, or V must be sent electronically. Provides that notwithstanding any other provision of law, a prescriber shall not be required to issue prescriptions electronically if he or she certifies to the Department of Financial and Professional Regulation that he or she will not issue more than 25 prescriptions during a 12-month period. Prescriptions in both oral and written form for controlled substances shall be included in determining whether the prescriber will reach the limit of 25 prescriptions. Provides that the Department of Financial and Professional Regulation shall adopt rules for the administration of these provisions. Provides that these rules shall provide for the implementation of any such exemption to the requirements under these provisions that the Department of Financial and Professional Regulation may deem appropriate, including the exemption limiting a prescriber from issuing more than 25 prescriptions during a 12-month period. Effective January 1, 2023.
